EyePoint, Inc. (EYPT)
0.3484
-0.03
(-8.32%)
USD |
NASDAQ |
Oct 30, 16:00
0.3403
-0.01
(-2.32%)
After-Hours: 20:00
EyePoint 30-Day Average Daily Volume : 12.97M for Oct. 30, 2026
30-Day Average Daily Volume Chart
Historical 30-Day Average Daily Volume Data
| Date | Value |
|---|---|
| October 30, 2026 | 12.97M |
| October 29, 2026 | 13.01M |
| October 28, 2026 | 13.02M |
| October 27, 2026 | 12.97M |
| October 26, 2026 | 12.78M |
| October 23, 2026 | 12.49M |
| October 22, 2026 | 12.14M |
| October 21, 2026 | 11.87M |
| October 20, 2026 | 10.91M |
| October 19, 2026 | 9.286M |
| October 16, 2026 | 3.204M |
| October 15, 2026 | 3.199M |
| October 14, 2026 | 3.262M |
| October 13, 2026 | 3.265M |
| October 12, 2026 | 3.298M |
| October 09, 2026 | 3.382M |
| October 08, 2026 | 3.517M |
| October 07, 2026 | 3.517M |
| October 06, 2026 | 3.554M |
| October 05, 2026 | 3.627M |
| October 02, 2026 | 3.808M |
| October 01, 2026 | 3.951M |
| September 30, 2026 | 4.148M |
| September 29, 2026 | 4.575M |
| September 28, 2026 | 6.233M |
| Date | Value |
|---|---|
| September 25, 2026 | 6.206M |
| September 24, 2026 | 6.172M |
| September 23, 2026 | 6.170M |
| September 22, 2026 | 6.171M |
| September 21, 2026 | 6.081M |
| September 18, 2026 | 6.008M |
| September 17, 2026 | 5.840M |
| September 16, 2026 | 5.689M |
| September 15, 2026 | 5.621M |
| September 14, 2026 | 5.541M |
| September 11, 2026 | 5.514M |
| September 10, 2026 | 5.475M |
| September 09, 2026 | 5.399M |
| September 08, 2026 | 5.356M |
| September 04, 2026 | 5.327M |
| September 03, 2026 | 5.313M |
| September 02, 2026 | 5.268M |
| September 01, 2026 | 5.146M |
| August 31, 2026 | 5.090M |
| August 28, 2026 | 5.010M |
| August 27, 2026 | 4.906M |
| August 26, 2026 | 4.758M |
| August 25, 2026 | 4.699M |
| August 24, 2026 | 4.597M |
| August 21, 2026 | 4.495M |
30-Day Average Daily Volume Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
30-Day Average Daily Volume Benchmarks
| Ocular Therapeutix, Inc. | 3.566M |
| Regeneron Pharmaceuticals, Inc. | 753586.4 |
| Corcept Therapeutics, Inc. | 942164.1 |
| Eli Lilly & Co. | 2.448M |
| Context Therapeutics, Inc. | 1.065M |